Report Detail

Request for Sample of this report

Pharma & Healthcare Global Insulin Glargine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3053756
    • |
  • 05 March, 2019
    • |
  • Global
    • |
  • 102 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).

Scope of the Report:
Insulin glargine is a long-acting, man-made version of human insulin. Insulin glargine works by replacing the insulin that is normally produced by the body and by helping move sugar from the blood into other body tissues where it is Used for energy. It also stops the liver from producing more sugar.

There are two type of Insulin glargine, which are Single Dose Vial and Pre-filled Syringe in the market. Considering its function, Insulin glargine is Used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also Used to treat people with type 2 diabetes (condition in which the body does not Used insulin normally and, therefore, cannot control the amount of sugar in the blood) who need insulin to control their diabetes.

We can see that there are just a few companies produce Insulin glargine, the production of them almost approach to 70% of whole market. They have seted plant in Japan, China, German, India, North Americato produce Insulin glargine, and China is the largest plant for Insulin glargine in the world and also the largest consumption country. As the amount of diabetes of increasing of China, the Chinese market will be bigger than North America.

The Industry is affected by the economic development level and policy, so it’s important to put an eye to economic indexes and leaders’ prefer. With the global economic recovery, more and more people pay attention to care about personal health, especially in underdevelopment regions that have a large population and fast economic growth, the need of Insulin glargine will increase.

The worldwide market for Insulin Glargine is expected to grow at a CAGR of roughly 4.1% over the next five years, will reach 7240 million US$ in 2024, from 5690 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Insulin Glargine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Sanofi-Aventis
Ganlee
Biocon

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Single Dose Vial
Pre-filled Syringe

Market Segment by Applications, can be divided into
Treat type2 diabetes
Treat type1 diabetes

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Insulin Glargine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Insulin Glargine, with price, sales, revenue and global market share of Insulin Glargine in 2017 and 2018.
Chapter 3, the Insulin Glargine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Insulin Glargine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Insulin Glargine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Insulin Glargine sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Insulin Glargine Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Single Dose Vial
      • 1.2.2 Pre-filled Syringe
    • 1.3 Market Analysis by Applications
      • 1.3.1 Treat type2 diabetes
      • 1.3.2 Treat type1 diabetes
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Sanofi-Aventis
      • 2.1.1 Business Overview
      • 2.1.2 Insulin Glargine Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Sanofi-Aventis Insulin Glargine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Ganlee
      • 2.2.1 Business Overview
      • 2.2.2 Insulin Glargine Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Ganlee Insulin Glargine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Biocon
      • 2.3.1 Business Overview
      • 2.3.2 Insulin Glargine Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Biocon Insulin Glargine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Insulin Glargine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Insulin Glargine Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Insulin Glargine Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Insulin Glargine Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Insulin Glargine Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Insulin Glargine Market Analysis by Regions

    • 4.1 Global Insulin Glargine Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Insulin Glargine Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Insulin Glargine Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Insulin Glargine Sales and Growth Rate (2014-2019)
    • 4.3 Europe Insulin Glargine Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Insulin Glargine Sales and Growth Rate (2014-2019)
    • 4.5 South America Insulin Glargine Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Insulin Glargine Sales and Growth Rate (2014-2019)

    5 North America Insulin Glargine by Country

    • 5.1 North America Insulin Glargine Sales, Revenue and Market Share by Country
      • 5.1.1 North America Insulin Glargine Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Insulin Glargine Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Insulin Glargine Sales and Growth Rate (2014-2019)
    • 5.3 Canada Insulin Glargine Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Insulin Glargine Sales and Growth Rate (2014-2019)

    6 Europe Insulin Glargine by Country

    • 6.1 Europe Insulin Glargine Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Insulin Glargine Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Insulin Glargine Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Insulin Glargine Sales and Growth Rate (2014-2019)
    • 6.3 UK Insulin Glargine Sales and Growth Rate (2014-2019)
    • 6.4 France Insulin Glargine Sales and Growth Rate (2014-2019)
    • 6.5 Russia Insulin Glargine Sales and Growth Rate (2014-2019)
    • 6.6 Italy Insulin Glargine Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Insulin Glargine by Country

    • 7.1 Asia-Pacific Insulin Glargine Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Insulin Glargine Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Insulin Glargine Revenue and Market Share by Country (2014-2019)
    • 7.2 China Insulin Glargine Sales and Growth Rate (2014-2019)
    • 7.3 Japan Insulin Glargine Sales and Growth Rate (2014-2019)
    • 7.4 Korea Insulin Glargine Sales and Growth Rate (2014-2019)
    • 7.5 India Insulin Glargine Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Insulin Glargine Sales and Growth Rate (2014-2019)

    8 South America Insulin Glargine by Country

    • 8.1 South America Insulin Glargine Sales, Revenue and Market Share by Country
      • 8.1.1 South America Insulin Glargine Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Insulin Glargine Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Insulin Glargine Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Insulin Glargine Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Insulin Glargine Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Insulin Glargine by Countries

    • 9.1 Middle East and Africa Insulin Glargine Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Insulin Glargine Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Insulin Glargine Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Insulin Glargine Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Insulin Glargine Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Insulin Glargine Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Insulin Glargine Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Insulin Glargine Sales and Growth Rate (2014-2019)

    10 Global Insulin Glargine Market Segment by Type

    • 10.1 Global Insulin Glargine Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Insulin Glargine Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Insulin Glargine Revenue and Market Share by Type (2014-2019)
    • 10.2 Single Dose Vial Sales Growth and Price
      • 10.2.1 Global Single Dose Vial Sales Growth (2014-2019)
      • 10.2.2 Global Single Dose Vial Price (2014-2019)
    • 10.3 Pre-filled Syringe Sales Growth and Price
      • 10.3.1 Global Pre-filled Syringe Sales Growth (2014-2019)
      • 10.3.2 Global Pre-filled Syringe Price (2014-2019)

    11 Global Insulin Glargine Market Segment by Application

    • 11.1 Global Insulin Glargine Sales Market Share by Application (2014-2019)
    • 11.2 Treat type2 diabetes Sales Growth (2014-2019)
    • 11.3 Treat type1 diabetes Sales Growth (2014-2019)

    12 Insulin Glargine Market Forecast (2019-2024)

    • 12.1 Global Insulin Glargine Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Insulin Glargine Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Insulin Glargine Market Forecast (2019-2024)
      • 12.2.2 Europe Insulin Glargine Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Insulin Glargine Market Forecast (2019-2024)
      • 12.2.4 South America Insulin Glargine Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Insulin Glargine Market Forecast (2019-2024)
    • 12.3 Insulin Glargine Market Forecast by Type (2019-2024)
      • 12.3.1 Global Insulin Glargine Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Insulin Glargine Market Share Forecast by Type (2019-2024)
    • 12.4 Insulin Glargine Market Forecast by Application (2019-2024)
      • 12.4.1 Global Insulin Glargine Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Insulin Glargine Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Insulin Glargine. Industry analysis & Market Report on Insulin Glargine is a syndicated market report, published as Global Insulin Glargine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Insulin Glargine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,742.24
      		4,113.36
      		5,484.48
      		3,201.60
      		4,802.40
      		6,403.20
      		541,557.60
      		812,336.40
      		1,083,115.20
      		290,162.40
      		435,243.60
      		580,324.80
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo